ABSTRACT
The corpus callosum (CC) is a thick band of nerve fibers that divides the cerebral cortex lobes into the left and right hemispheres. Prenatal diagnosis of corpus callosum agenesis (partial/total) has been described frequently in the literature. In this case report, a case of corpus callosum dysplasia with different development of the halves of the corpus callosum in the right and left brain hemispheres, which was not previously discussed in the literature, will be described. Whenever we have any doubts about CC, axial, coronal, and sagittal scans of the fetal brain should be performed with TVUSG (transvaginal ultrasonography) or TAUSG (transabdominal ultrasonography) according to the position of the fetal head, and both length and thickness should be measured.
Subject(s)
Corpus Callosum , Ultrasonography, Prenatal , Agenesis of Corpus Callosum/complications , Agenesis of Corpus Callosum/diagnostic imaging , Corpus Callosum/diagnostic imaging , Female , Humans , Pregnancy , Prenatal DiagnosisABSTRACT
INTRODUCTION: Severe fetal anemia may cause cardiac ischemia, reduced contractility, and dysfunction. The purpose of our study is to evaluate right ventricular myocardial performance index (MPI) before and after intrauterine transfusion (IUT) in patients who underwent this procedure because of fetal anemia due to Rh-D alloimmunization. MATERIALS AND METHODS: This prospective cohort study was conducted between January 2018 and June 2019 at Kanuni Sultan Suleyman Research and Training Hospital, Istanbul, Turkey. The pregnant women who were applied IUT because of fetal anemia due to Rh-D alloimmunization in our perinatology clinic were included in the study. Fetal right ventricular MPI before and 24 h after IUT were evaluated. RESULTS: A total of 28 IUTs were performed in 17 pregnant women during the study period. The isovolumetric contraction time (ICT) and isovolumetric relaxation time (IRT) values measured before IUT, were found to be significantly longer compared to the ICT and IRT values measured after IUT. The MPI values measured after transfusion was found to be higher than before transfusion. CONCLUSIONS: The fetal right ventricular MPI increases 24 h after IUT. This increase in the right ventricular MPI might be used as a marker for predicting adverse fetal outcomes following IUT.
Subject(s)
Fetal Diseases , Rh Isoimmunization , Blood Transfusion, Intrauterine , Female , Fetal Diseases/diagnostic imaging , Humans , Pregnancy , Prospective Studies , Rh Isoimmunization/complications , TurkeyABSTRACT
Objective: Metabolic changes and inflammation are involved in the pathogenesis of preeclampsia. Complement C1q tumor necrosis factor-related protein-1 (CTRP-1) is a pleiotropic molecule that possesses insulin-sensitizing effects and is also involved in lipid metabolism and inflammatory responses. The aim of the study was to investigate CTRP-1 levels in pregnancies with preeclampsia.Material and methods: Serum concentrations of CTRP-1 were measured in 29 pregnant women with early-onset preeclampsia (EOPE), 24 pregnant women with late-onset preeclampsia (LOPE), and 26 women with uncomplicated pregnancies using an enzyme-linked immunosorbent assay method.Results: Patients with both EOPE and LOPE had significantly higher serum concentrations of CTRP-1 compared to the healthy controls (p < .001). However, no significant difference was found between the EOPE and LOPE groups regarding CTRP-1 levels (p = 1.000). Correlation analysis showed that CTRP-1 levels were positively correlated with systolic blood pressure (p < .001), diastolic blood pressure (p < .001), and mean UtA PI (p < .001) but negatively correlated with gestational age at delivery (p = .001) and birth weight (p < .001).Conclusions: Serum CTRP-1 levels were significantly higher in patients with both EOPE and LOPE than in healthy pregnant women.
Subject(s)
Pre-Eclampsia/blood , Proteins/metabolism , Adult , Cross-Sectional Studies , Female , Humans , Pregnancy , Young AdultABSTRACT
Our aim was to assess the relationship between gestational diabetes and glucose intolerance regarding maternal serum PAPP-A and free ß-hCG concentrations in first trimester pregnancies. This study was conducted on 278 women between 18-45 years old with singleton pregnancies. The subjects were divided into four groups, according to their 50 and 100 g OGTT results. Group 1 was the Control Group, Group 2 with positive 50 g OGTT results, but negative 100 g, Group 3 had gestational diabetes after testing with 50 g OGTT (≥180 mg/dl) or with 100 g OGTT. Finally Group 4 was made of women with a one single high glucose level after testing with 100 g OGTT. These groups were analysed in terms of OGTT results. In the GDM group, serum PAPP-A concentrations were significantly lower when compared with the Control Group's (p = 0.015). There was either no significant differences regarding free ß-hCG concentrations among the groups. GDM rate is 21.1%, the patients with GDM had significantly low concentrations of serum PAPP-A but their f ß-hCG concentrations did not change. Our results are supported by several studies. However, we need greater numbered studies for exact results.IMPACT STATEMENTWhat is already known on this subject? Pregnancy associated plasma protein A (PAPP-A) is produced by the placenta in pregnancy. PAPP-A cleaves insulin-like growth factor (IGF) binding proteins. It would appear to have a role in regulating IGF bioavailability in pregnancy. This is important as the IGF axis plays a critical role in fetal growth, and placental growth and function during pregnancy. Some studies have reported that PAPP-A levels were impaired among women who subsequently developed GDM.What do the results of this study add? The patients with GDM had significantly low concentrations of serum PAPP-A but their free ß-hCG levels did not change.What are the implications of these findings for clinical practice and/or further research? By looking at PAPP-A concentrations, we can predict patients that will be gestational diabetic and take precautions to protect the babies health, such as their diet or exercise.
Subject(s)
Chorionic Gonadotropin, beta Subunit, Human/blood , Diabetes, Gestational/blood , Maternal Serum Screening Tests/statistics & numerical data , Pregnancy Trimester, First/blood , Pregnancy-Associated Plasma Protein-A/analysis , Adolescent , Adult , Biomarkers/blood , Case-Control Studies , Female , Glucose Tolerance Test , Humans , Middle Aged , Predictive Value of Tests , Pregnancy , Young AdultABSTRACT
Background This study aimed to investigate fetal cardiac functions by spectral tissue Doppler imaging (s-TDI) in pregnancies complicated with late-onset fetal growth restriction (LO-FGR) and small-for-gestational age (SGA). Methods Forty pregnancies complicated with late-onset FGR and 40 pregnancies complicated with SGA between the 34th and 37th weeks of gestation were enrolled in this study. Forty gestational age-matched pregnant women with no obstetrics complication were randomly selected as a control group. Small fetuses were classified as fetal growth restriction or SGA according to estimated fetal weight (EFW), umbilical artery pulsatility index (PI), cerebroplacental ratio (CPR) and uterine artery PI. s-TDI measurements were obtained at the right atrioventricular valve annulus. Results SGA and LO-FGR fetuses had significantly lower A' and S' values, and higher E'/A' ratio than the control group (P < 0.001). In comparison to controls, significantly prolonged isovolumetric contraction time (ICT') and isovolumetric relaxation time (IRT') and, significantly shortened ejection time (ET') were observed in fetuses with SGA and LO-FGR. Increased myocardial performance index (MPI') values were also found in fetuses with SGA and LO-FGR compared to controls. Conclusion The signs of cardiac dysfunction were observed both in fetuses with SGA and LO-FGR. The fetal cardiac function assessment with s-TDI could be a valuable method in the diagnosis of true growth restricted fetuses and in the management of these fetuses.
Subject(s)
Fetal Growth Retardation/physiopathology , Fetal Heart/physiopathology , Adult , Female , Fetal Growth Retardation/diagnostic imaging , Fetal Heart/diagnostic imaging , Humans , Infant, Newborn , Infant, Small for Gestational Age , Pregnancy , Ultrasonography, Doppler , Young AdultABSTRACT
Purpose: We investigated the optimal cut-off level for urinary neutrophil gelatinase-associated lipocalin (NGAL) in preeclamptic patients to confirm the diagnosis. Methods: Urinary NGAL concentrations were measured by specific enzyme-linked immunosorbent assay (ELISA). Results: Patients with preeclampsia had significantly higher urinary NGAL concentrations than controls (mean: 387 ng/ml vs. 188 ng/ml, respectively; P< 0.001). Using a cutoff value 252 ng/ml for urinary NGAL to confirm diagnosis of preeclampsia, sensitivity, and specificity were 92% and 91%, respectively. Conclusion: Urinary NGAL concentrations were significantly elevated in women with preeclampsia versus normotensive controls.
Subject(s)
Lipocalin-2/urine , Pre-Eclampsia/diagnosis , Adult , Biomarkers/urine , Case-Control Studies , Female , Humans , Pre-Eclampsia/urine , Pregnancy , TurkeyABSTRACT
Left pulmonary artery sling (LPAS) is a very rare cause of large airway compression. In LPAS, the left pulmonary artery (LPA) arises from the proximal right pulmonary artery, coursing over the right mainstem bronchus, posterior to the trachea and anterior to the esophagus prior to reaching the left hilum. The aberrant course of the LPA results in anatomical obstruction of the right mainstem bronchus, the trachea, or both. Only a few reports present the prenatal features of LPAS. In this report, we present the prenatal diagnosis of a case of LPAS in one of a set of identical twins in which the only feature was that of an abnormal course of the LPA on 3-vessel tracheal view. The cross-sectional view at the level of three vessels which includes both pulmonary artery branches is useful to detect this abnormality. Color and power Doppler may be helpful as well.
Subject(s)
Echocardiography/methods , Pulmonary Artery/abnormalities , Pulmonary Artery/diagnostic imaging , Ultrasonography, Prenatal/methods , Adult , Female , Humans , Infant , Pregnancy , Pulmonary Artery/embryology , TwinsABSTRACT
OBJECTIVES: To investigate liver-derived plasma protein fetuin B levels in healthy pregnant women and pregnant women with intrahepatic cholestasis of pregnancy (ICP). MATERIALS AND METHODS: Forty women with ICP and 40 healthy pregnant women were included in this cross-sectional study. The serum fetuin B levels of these patients were analyzed. The patients were followed up to delivery. RESULTS: Maternal age, gravida, parity, BMI at assessment, and gestational age at blood sampling were similar between the ICP and control groups (p > .05). However, the gestational age at delivery and the birth weight were significantly lower in the ICP group (p < .05). Total bile acid (TBA) levels and liver function tests were significantly higher in the ICP group than in the control group (p < .0001 and < .0001, respectively). In addition, serum fetuin B concentrations were significantly higher in the ICP group than in the control group (p < .0001). The best cutoff for fetuin B serum concentration was 5540.2 pg/mL. Serum values greater than this threshold had 80% sensitivity and 65% specificity for the diagnosis of ICP. CONCLUSIONS: Serum fetuin B was higher in patients with ICP compared to healthy pregnant women and might be a new biomarker.
Subject(s)
Cholestasis, Intrahepatic/blood , Fetuin-B/analysis , Pregnancy Complications/blood , Adult , Bile Acids and Salts/blood , Biomarkers/blood , Birth Weight , Case-Control Studies , Cholestasis, Intrahepatic/diagnosis , Cross-Sectional Studies , Female , Gestational Age , Humans , Infant, Newborn , Pregnancy , Pregnancy Complications/diagnosis , ROC Curve , Young AdultABSTRACT
OBJECTIVE: Growth differentiation factor-15 (GDF-15) is a stress-induced cytokine and related to the prognosis of cardiovascular diseases. Our purpose is to measure the maternal levels of GDF-15 in patients with early-onset preeclampsia (EOPE) and late-onset preeclampsia (LOPE). METHODS: This cross-sectional study was conducted including 72 pregnant women, 23 with normal pregnancies and 49 with preeclampsia (26 with EOPE and 23 with LOPE). Maternal serum levels of GDF-15 were measured by using enzyme-linked immunosorbent assay kits. RESULTS: The median serum GDF-15 level was found to be the highest in the EOPE group (EOPE: 441.7 pg/ml). The median serum GDF-15 levels were higher in women with preeclampsia than in the control group (309.7 pg/ml vs. 436.6 pg/ml, p: 0.009). CONCLUSION: Our findings suggest GDF-15 increased as a response to endothelial injury caused by cytokines triggered by preeclampsia.
Subject(s)
Growth Differentiation Factor 15/blood , Pre-Eclampsia/blood , Adult , Cross-Sectional Studies , Female , Humans , Pregnancy , Pregnancy Trimester, Third/blood , Young AdultABSTRACT
OBJECTIVE: The aim of this study was to evaluate utilization, efficacy, and side effects of flecainide treatment as first-line agent in patients with fetal supraventricular tachycardia (SVT). METHOD: This retrospective review was conducted on 23 consecutive fetal tachyarrhythmia cases that met inclusion criteria. If the treatment was necessary, then flecainide was used as first-line treatment in all cases. RESULT: Among the study group, there were 21 (91.3%) cases of SVT and 2 (8.6%) cases of Atrial Flutter (AF). Sixteen fetuses had persistent SVT and five fetuses had intermittent SVT. We treated 17 fetuses with flecainide monotherapy and 15 of them converted to sinus rhythm and remaining two fetuses were refractory to monotherapy. The median time to conversion to sinus rhythm was 3.8 ± 1.6 days. Only one fetus (20%) among the intermittent SVT cases required anti-arrhythmic treatment. CONCLUSION: Our study has demonstrated that flecainide is an effective first-line treatment for fetal SVT with high success rate (88.2%), low side effect profile and relatively easy utilization. Based on the current study and recently published article results, flecainide can be recommended as the drug of first choice for treatment of fetal SVT cases.
Subject(s)
Anti-Arrhythmia Agents/therapeutic use , Fetal Diseases/drug therapy , Flecainide/therapeutic use , Tachycardia, Supraventricular/drug therapy , Adult , Echocardiography , Female , Fetal Heart/diagnostic imaging , Gestational Age , Humans , Hydrops Fetalis/etiology , Infant, Newborn , Pregnancy , Retrospective Studies , Tachycardia, Supraventricular/complications , Treatment Outcome , Ultrasonography, Doppler , Young AdultABSTRACT
OBJECTIVE: A cesarean scar pregnancy (CSP) is an extremely rare form of an ectopic pregnancy, which is defined as the localization of a fertilized ovum surrounded by uterine muscular fiber and scar tissue. The objective of this study was to discuss the management options for CSPs in a singleton center. In the current study, we discussed the current management options for CSPs based on our 6 years of experience. MATERIAL AND METHODS: A retrospective evaluation of diagnosed and treated 26 patients with CSPs in Istanbul Kanuni Sultan Suleyman Training and Research Hospital during a 6-year period was discussed. Suction curettage was performed as first-line treatment in patients with a gestation <8 weeks and myometrial thickness >2 mm. RESULTS: Twenty-two (84.6%) patients with CSPs were initially treated surgically (curettage and hysterotomy) and four (15.4%) patients were treated medically with methotrexate injections. Vacuum aspiration was performed in 19 patients as a first-line treatment, six of them needed an additional Foley balloon catheter to be inserted for tamponade because of persistent vaginal bleeding. Suction curettage was successful in 12 patients. The treatment rate for suction curettage with or without Foley balloon catheter tamponade was 16 of 19 (84.2%). CONCLUSION: The early diagnosis of a CSP (7-8 weeks gestation) with a ß-hCG level <17.000 mIU/ml and a myometrial thickness >2 mm can be treated with suction curettage with or without placement of a uterine Foley balloon as curative treatment.
Subject(s)
Cesarean Section , Cicatrix/surgery , Pregnancy, Ectopic/surgery , Vacuum Curettage , Abortion, Eugenic/adverse effects , Abortion, Eugenic/methods , Adult , Cesarean Section/adverse effects , Cesarean Section/statistics & numerical data , Cicatrix/complications , Cicatrix/epidemiology , Feasibility Studies , Female , Gestational Age , Humans , Hysterectomy/statistics & numerical data , Methotrexate/administration & dosage , Parity , Pregnancy , Pregnancy, Ectopic/epidemiology , Retrospective Studies , Treatment Outcome , Vacuum Curettage/adverse effects , Young AdultABSTRACT
Uterine arteriovenous malformation (AVM), an extremely rare condition, is defined as an abnormal connection between artery and vein. Although the pelvis is a common site for AVM, the uterus is involved occasionally and the true incidence is unknown. The objective of this study was to discuss diagnostic features and management options of AVMs. In this paper six cases of AVMs have been reported with a review of diagnosis and management options.
Subject(s)
Arteriovenous Malformations/diagnostic imaging , Ultrasonography/methods , Uterine Artery Embolization/methods , Uterine Artery/abnormalities , Uterine Hemorrhage/diagnostic imaging , Uterine Hemorrhage/therapy , Adult , Diagnosis, Differential , Female , Humans , Treatment Outcome , Uterine Artery/diagnostic imaging , Uterine Hemorrhage/etiologyABSTRACT
Fetal sacrococcygeal teratomas (SCTs) occur in one to two per 20 000 pregnancies that cause high-output cardiac failure. High-output cardiac failure leads to polyhydramnios, hydrops, intrauterine fetal demise and preterm birth. Vascular disruption defects refer to those involving the interruption or destruction of some part of the fetal vasculature. We present a rare case of huge SCT causing multiple fetal disruption defects like cleft lip and palate and limb anomalies besides hydrops.
Subject(s)
Abnormalities, Multiple/embryology , Blood Vessels/abnormalities , Spinal Neoplasms/complications , Teratoma/complications , Adult , Arm/abnormalities , Cleft Lip/etiology , Cleft Palate/etiology , Fatal Outcome , Female , Gestational Age , Humans , Infant, Newborn , Pregnancy , Sacrococcygeal RegionABSTRACT
Congenital high airway obstruction syndrome (CHAOS) is an extremely rare life-threatening condition. Laryngeal atresia appears to be the most frequent cause. Generally the diagnosis is made with severely enlarged and highly echogenic lungs and additional ultrasound findings. The prognosis of the affected infants is often poor. Five cases are reported here that were diagnosed in a tertiary center between 2008 and 2014.
Subject(s)
Abnormalities, Multiple/diagnostic imaging , Airway Obstruction/congenital , Airway Obstruction/diagnostic imaging , Larynx/abnormalities , Trachea/abnormalities , Ultrasonography, Prenatal/methods , Adult , Female , Humans , Larynx/diagnostic imaging , Pregnancy , Syndrome , Trachea/diagnostic imagingABSTRACT
OBJECTIVE: We aimed to determine whether the risks of adverse outcomes were greater in women who had pregnancies ending in stillbirth than in those with no previous history of stillbirth. METHODS: This retrospective cohort study included all women who had undergone their first and second deliveries at Bakirkoy Women's and Children's Education and Research Hospital between 2002 and 2011. Women who delivered following a previous stillbirth after 20 complete weeks of gestation were compared with those who had delivered but had no history of stillbirth after 20 weeks of gestation. RESULTS: We compared 201 subsequent births to women with previous histories of stillbirth with 402 live births to women with no such history. The rates of pre-eclampsia [odds ratio (OR), 3.4; 95% confidence interval (CI), 1.5-7.4], HELLP syndrome (OR, 3.1; 95% CI, 1.2-9.6), low birth weight (OR, 1.6; 95% CI, 0.7-3.5) and malpresentation (OR, 2.9; 95% CI, 1.6-4.8) were significantly higher in the case group. Howewer, the rates of stillbirth were similar between the groups. CONCLUSION: We found increased rates of obstetric and perinatal complications in subsequent pregnancies in women with histories of stillbirth. Thus, the results of this study suggest that pregnant women with histories of stillbirth should be followed closely, beginning in the early gestational period.
Subject(s)
Abruptio Placentae/etiology , HELLP Syndrome/etiology , Infant, Low Birth Weight , Obstetric Labor Complications/etiology , Pre-Eclampsia/etiology , Stillbirth , Abruptio Placentae/epidemiology , Adult , Case-Control Studies , Cohort Studies , Female , HELLP Syndrome/epidemiology , Humans , Infant, Newborn , Logistic Models , Multivariate Analysis , Obstetric Labor Complications/epidemiology , Odds Ratio , Pre-Eclampsia/epidemiology , Pregnancy , Retrospective Studies , Risk FactorsABSTRACT
Epidermolysis bullosa with pyloric atresia (EB-PA) is a rare autosomal recessive disease that is characterized by fragility of the skin and mucous membranes. The course of EB-PA is usually severe and often lethal in the neonatal period. In most cases, prenatal diagnosis of this syndrome is considered in pregnancies at risk for recurrence. EB-PA can be described during pregnancy with sonographic signs such as polyhydramnios with a dilated stomach, the "snowflake sign", which are echogenic particles in the amniotic fluid, and several other anomalies. In this report, we present three cases of EB-PA suggested by the results of prenatal sonography, and describe a new ultrasonographic sign, i.e., complete chorioamniotic membrane separation, which can be helpful for the diagnosis. The prenatal diagnoses were confirmed postnatally. Two of the three cases had no family history, and one of these two cases was the product of a non-consanguineous couple.
Subject(s)
Ectodermal Dysplasia/diagnostic imaging , Fetal Diseases/diagnostic imaging , Ultrasonography, Prenatal , Adult , Diagnosis, Differential , Ectodermal Dysplasia/pathology , Ectodermal Dysplasia/surgery , Fatal Outcome , Female , Fetal Diseases/pathology , Humans , Pregnancy , Young AdultABSTRACT
Non-immune hydrops fetalis (NIHF) is a challenging entity as it represents the end stage of several different disorders. Renal and genitourinary causes of NIHF are rare and include congenital renal malformations, tumors and ureter-urethra disorders. Herein, two NIHF cases with different renal causes were presented. The first case that had antenatal NIHF was diagnosed neonatal Bartter syndrome. The second case of NIHF with antenatal large cyst in the surrenal gland area required surgery and ectopic renal cyst was diagnosed. To our best of knowledge, these are the first reports of NIHF associated with neonatal Bartter syndrome and ectopic renal cyst in neonates. Although it may be coincidental, these cases suggest that both neonatal Bartter syndrome and unilateral ectopic renal cyst may cause NIHF development in neonates by several different mechanisms. Therefore, these two rare entities should be suspected in cases of NIHF with similar findings.
Subject(s)
Adrenal Gland Diseases/complications , Bartter Syndrome/complications , Choristoma/complications , Hydrops Fetalis/etiology , Kidney Diseases, Cystic/complications , Kidney , Adrenal Gland Diseases/diagnosis , Adult , Bartter Syndrome/diagnosis , Choristoma/diagnosis , Female , Humans , Hydrops Fetalis/diagnosis , Infant, Newborn , Kidney Diseases, Cystic/diagnosis , Male , PregnancyABSTRACT
Liver tumors seldom occur in the perinatal period. Hepatic hemangiomas are the most common tumors of the liver diagnosed during fetal and neonatal life. The diagnosis can be suspected antenatally by ultrasound and MR scan. The differential diagnosis is often challenging. While small hepatic hemangiomas are usually asymptomatic, large tumors can lead to complications such as high-output congestive heart failure, consumptive thrombocytopenic coagulopathy and hemorrhage after tumor rupture. We describe a case of hepatic hemangioma presenting as a solid abdominal mass with several cystic areas on an obstetric ultrasound and report on the contribition fetal MR imaging to the diagnosis.
Subject(s)
Hemangioma, Cavernous/diagnosis , Liver Neoplasms/diagnosis , Prenatal Diagnosis/methods , Adult , Female , Fetal Death/etiology , Hemangioma, Cavernous/congenital , Hemangioma, Cavernous/diagnostic imaging , Humans , Hydrops Fetalis/etiology , Liver Neoplasms/congenital , Liver Neoplasms/diagnostic imaging , Magnetic Resonance Imaging , Pregnancy , Ultrasonography, PrenatalABSTRACT
OBJECTIVES: Trapidil is an antianginal compound with a broad spectrum of pharmacological activities. In recent years, it has been used successfully to decrease ischemia-reperfusion injury in several organ systems. We evaluated the effect of trapidil on the long-term histologic damage in testicular ischemia-reperfusion injury. METHODS: Adult male Wistar rats were divided into three groups of six rats each. One group underwent 2 h of testicular torsion; one received pretreatment with trapidil before detorsion; and one group underwent sham operation. All rats underwent bilateral orchiectomy 60 days after the experiment. The mean seminiferous tubular diameter, germinal epithelial cell thickness, and mean testicular biopsy score were determined by histological examination of each testis. RESULTS: Testicular torsion-detorsion caused a significant decrease in the mean seminiferous tubular diameter, germinal epithelial cell thickness, and mean testicular biopsy score in the ipsilateral testes, but not in the contralateral testes. The animals treated with trapidil had a significant increase in these histological parameters as compared to the torsion-detorsion group. CONCLUSION: Trapidil administration before reperfusion may have the potential to decrease the long-term histologic damage that occurs after experimental testicular torsion. Trapidil is used as an antianginal drug and additional clinical studies are required to elucidate the protective role of trapidil in patients with testicular torsion.